Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1823
| Despition | SOX2 Human Recombinant, TAT Tag |
| SIZE | 5 µg |
| Purity | > 95.0% by RP-HPLC and SDS-PAGE |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1325 | Synaptotagmin 1 Blocking Peptide (AC1325) | 250 µg | inquiry |
| ACPP-1155 | Recombinant Human PCDH18 Protein (6×His Tag) (AC1155) | 50 µg | inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1076 | Synaptophysin Blocking Peptide (AC1076) | 250 µg | inquiry |
| ACPP-1471 | Human SCG3 Protein (AC1471) | 5 µg | inquiry |
| ACPP-1778 | Human HSD17B10 Protein (AC1778) | 2 µg | inquiry |
| ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
| ACPP-1686 | Human Acrp30 Protein, HEK (AC1686) | 2 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1228 | Mouse IL 6 Protein (AC1228) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.